MCL-1 inhibitors

The present invention relates generally to compounds and pharmaceutical compositions useful in methods of treating cancer. In particular, the present invention relates to MCL-1 inhibitors. 本发明总体上涉及化合物和药物组合物，其可用于治疗癌症的方法。具体地，本发明涉及MCL-1抑制剂。...

Full description

Saved in:
Bibliographic Details
Main Authors MITCHELL, MICHAEL, L, WATKINS WILLIAM J, YANG HANBIAO, MEDLEY JONATHAN WILLIAM, TSUI VICKIE H, NEWBY ZACHARY, HOANG TRI HAI, JIANG LIBIN, KOBAYASHI, TOSHIKAZU, LIN DAVID W, LI XIA, VENKATARAMANI CHANDRASEKAR, LAZERWITH SCOTT E, KATO DARRYL, SQUIERS NEIL H, CHU HENRY, GUERRERO JUAN A, NADUTHAMBY, DAVID, HURTLEY AMY E, KNOX JOHN E
Format Patent
LanguageChinese
English
Published 29.12.2023
Subjects
ACYCLIC OR CARBOCYCLIC COMPOUNDS
CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
Online AccessGet full text

Cover

More Information
Summary:The present invention relates generally to compounds and pharmaceutical compositions useful in methods of treating cancer. In particular, the present invention relates to MCL-1 inhibitors. 本发明总体上涉及化合物和药物组合物，其可用于治疗癌症的方法。具体地，本发明涉及MCL-1抑制剂。
Bibliography:Application Number: CN202310897123